Cancer Research UK and MedImmune Launch Ground-Breaking Biotherapeutics Research Centre in Cambridge A new laboratory that will focus on the discovery and development of novel biologic cancer treatments and diagnostics has been opened this week in Cambridge. The state-of-the-art CRUK-MEDI Alliance Laboratory is an innovative collaboration between Cancer Research UK, its commercial arm Cancer Research Technology, and MedImmune, the global biologics research and development arm of AstraZeneca. [Cancer Research UK] Press Release Kite Pharma Expands Collaboration with Netherlands Cancer Institute Kite Pharma, Inc. announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite and the NKI have entered into an agreement under which Kite will receive from the NKI the exclusive option to license multiple T cell receptor gene sequences for the development and commercialization of cancer immunotherapy candidates targeting solid tumors. [Kite Pharma, Inc.] Press Release Immunicum Provides Ad5PTDf35 Adenovirus Technology to Rutgers Cancer Institute Immunicum AB has signed a research agreement with Rutgers Cancer Institute of New Jersey to supply the institution with the company’s adenovirus (Ad5PTDf35) technology. [Immunicum AB] Press Release Stem Cell Specialists BioEden to Enter Strategic Alliance with Precious Cells Group BioEden is teaming up with Precious Cells Group, a London based Medtech Company whose facilities specialize in enabling the harvesting and banking of stem cells from cord blood and peripheral blood derived stem cells amongst others platform technologies. [BioEden (PRWeb)] Press Release International Stem Cell Corporation Announces Next Phase of Research Collaboration with Rohto Pharmaceutical Co., Ltd. of Japan International Stem Cell Corporation (ISCO) announced that it had entered into the second phase of the existing research agreement with Rohto Pharmaceutical Co., Ltd. After successfully completing preliminary studies of ISCO’s human parthenogenetic neural stem cells, Rohto acknowledged that ISCO’s proprietary cells demonstrate consistent high quality and are suitable for further use in Rohto’s research. [International Stem Cell Corporation] Press Release Childhood Cancer Research at UCSF to Transcend Tissue Types with Innovative Grant Researchers at UC San Francisco (UCSF) are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers rather than on a cancer in a particular organ or tissue in the body. [UC San Francisco] Press Release Baylor College of Medicine Receives Grant to Study Experimental Immunotherapy in HPV-Related Throat Cancer Researchers at Baylor College of Medicine have received a $1.1 million grant from the U.S. Food and Drug Administration to advance clinical studies of an experimental immunotherapy for human papillomavirus (HPV)-related throat cancer. [Baylor College of Medicine] Press Release Ogawa-Yamanaka Prize Founded at the Gladstone Institutes to Support Translational Stem Cell Research The Gladstone Institutes presented the inaugural Ogawa-Yamanaka Stem Cell Prize to Masayo Takahashi, MD, PhD, a faculty member and project leader in the Laboratory for Retinal Regeneration at the RIKEN Centre for Developmental Biology in Japan. Dr. Takahashi was awarded the prize for her trailblazing work leading the first clinical trial to use induced pluripotent stem cells in humans. [Gladstone Institutes] Press Release ASTRO Awards $33,500 in Individual Grants to 41 Researchers Presenting at 2015 Annual Meeting The American Society for Radiation Oncology (ASTRO) has selected 41 recipients to receive a total of $33,500 for the 2015 Annual Meeting Abstract Awards. [American Society for Radiation Oncology] Press Release |